Abstract
VALIDATED STABILITY INDICATING RP-HPLC METHOD FOR QUANTIFICATION OF SPARSENTAN IN PHARMACEUTICAL DOSAGE FORM: A 2023 USFDAAPPROVED DRUG
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have